tiprankstipranks
Iovance Biotherapeutics Inc (IOVA)
NASDAQ:IOVA
US Market

Iovance Biotherapeutics (IOVA) Cash flow

Compare
3,177 Followers

Iovance Biotherapeutics Cash Flow

IOVA's free cash flow for Q3 2024 was $-61.26M. For the 2024 fiscal year, IOVA's free cash flow was decreased by $-70.93M and operating cash flow was $-58.97M. See a summary of the company’s cash flow.
Cash Flow
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -361.82M$ -292.76M$ -227.94M$ -205.13M$ -158.89M
Investing Cash Flow
$ -155.24M$ 256.45M$ 132.00K$ -317.85M$ 90.03M
Financing Cash Flow
$ 462.96M$ 190.15M$ 239.27M$ 576.42M$ 6.13M
End Cash Position
$ 181.32M$ 238.16M$ 84.31M$ 72.85M$ 19.42M
Free Cash Flow
$ -384.11M$ -313.18M$ -265.51M$ -251.93M$ -165.81M
Currency in USD

Iovance Biotherapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis